ORTHO REGENERATIVE T

ORTH
Delayed Quote. Delayed  - 08/07 03:43:15 pm
0.41CAD --.--%
Income Statement Evolution
Annual Income Statement Data
Fiscal Period: January 2016 2017 2018 2019 2020
Net sales -----
EBITDA ---1,76-2,22-2,09
Operating profit (EBIT)1 -0,66-1,56-1,79-2,31-2,18
Operating Margin -----
Pre-Tax Profit (EBT)1 -0,93-1,66-2,02-2,40-2,49
Net income1 -0,93-1,66-2,02-2,40-2,49
Net margin -----
EPS2 -0,11-0,12-0,12-0,10-0,10
Dividend per Share -----
Last update 05/16/201705/18/201805/30/201905/29/202005/29/2020
1 CAD in Million
2 CAD
Finances - Leverage
Fiscal Period: January 2016 2017 2018 2019 2020
Net Debt1 -0,870,670,632,36
Net Cash position1 0,41----
Leverage (Debt / EBITDA) ---0,38x-0,28x-1,13x
Free Cash Flow --1,09-1,52-0,92-1,18
ROE (Net Profit / Equities) -364%361%1 084%167%
Shareholders' equity1 --0,46-0,56-0,22-1,49
ROA (Net Profit / Asset) --76,7%-98,9%-92,5%-94,4%
Assets1 -2,162,042,592,64
Book Value Per Share2 0,03-0,090,01-0,02-0,10
Cash Flow per Share2 0,050,000,020,020,01
Capex --0,160,08-
Capex / Sales -----
Last update 05/16/201705/18/201805/30/201905/29/202005/29/2020
1 CAD in Million
2 CAD
Balance Sheet Analysis
Price Earning Ratio
EPS & Dividend